How have the recent updated epilepsy classifications impacted on diagnosis and treatment?

References

• Proposal for classification of epilepsies and epileptic syndromes. Commission on classification and terminology of the international league against epilepsy. Epilepsia. 1985 May;26(3):268–278. doi: 10.1111/j.1528-1157.1985.tb05417.x
   PubMedGoogle Scholar
• Proposal for revised classification of epilepsies and epileptic syndromes. Commission on classification and terminology of the international league against epilepsy. Epilepsia. 1989 Jul;30(4):389–399. doi: 10.1111/j.1528-1157.1989.tb05316.x
   PubMed Web of Science ®Google Scholar
• Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for classification and terminology. Epilepsia. 2017 Apr;58(4):512–521. doi: 10.1111/epi.13709
   PubMed Web of Science ®Google Scholar
• Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017 Apr;58(4):522–530. doi: 10.1111/epi.13670
   PubMed Web of Science ®Google Scholar
• Fisher RS, Cross JH, D’Souza C, et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017 Apr;58(4):531–542. doi: 10.1111/epi.13671
   PubMed Web of Science ®Google Scholar
• Pressler RM, Cilio MR, Mizrahi EM, et al. The ILAE classification of seizures and the epilepsies: modification for seizures in the neonate. Position paper by the ILAE Task Force on neonatal seizures. Epilepsia. 2021 Mar;62(3):615–628. doi: 10.1111/epi.16815
   PubMed Web of Science ®Google Scholar
• Nagarajan L, Ghosh S, Palumbo L. Ictal electroencephalograms in neonatal seizures: characteristics and associations. Pediatr Neurol. 2011 Jul;45(1):11–16. doi: 10.1016/j.pediatrneurol.2011.01.009
   PubMed Web of Science ®Google Scholar
• Hirsch E, French J, Scheffer IE, et al. ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE Task Force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1475–1499. doi: 10.1111/epi.17236
   PubMed Web of Science ®Google Scholar
• Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia. 2005;46(Suppl 9):10–14. doi: 10.1111/j.1528-1167.2005.00309.x
   PubMed Web of Science ®Google Scholar
• Riney K, Bogacz A, Somerville E, et al. International league against epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1443–1474. doi: 10.1111/epi.17240
   PubMed Web of Science ®Google Scholar
• Specchio N, Wirrell EC, Scheffer IE, et al. International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1398–1442. doi: 10.1111/epi.17241
   PubMed Web of Science ®Google Scholar
• Wirrell EC, Nabbout R, Scheffer IE, et al. Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE Task Force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1333–1348. doi: 10.1111/epi.17237
   PubMed Web of Science ®Google Scholar
• Zuberi SM, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE Task Force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1349–1397. doi: 10.1111/epi.17239
   PubMed Web of Science ®Google Scholar
• Loscher W, Klein P. The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond. CNS Drugs. 2021 Sep;35(9):935–963. doi: 10.1007/s40263-021-00827-8
   PubMed Web of Science ®Google Scholar
• Glauser T, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013 Mar;54(3):551–563. doi: 10.1111/epi.12074
   PubMed Web of Science ®Google Scholar
• Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: treatment-resistant epilepsy: report of the American epilepsy society and the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Epilepsy Curr. 2018 Jul;18(4):269–278. doi: 10.5698/1535-7597.18.4.269
   PubMed Web of Science ®Google Scholar
• NICE guideline (NG217). Epilepsies in children, young people and adults 2022. Available from: https://www.nice.org.uk/guidance/ng217
   Google Scholar
• Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007 Mar 24;369(9566):1016–1026. doi: 10.1016/S0140-6736(07)60461-9
   PubMed Web of Science ®Google Scholar
• Marson A, Burnside G, Appleton R, et al. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet. 2021 Apr 10;397(10282):1375–1386. doi: 10.1016/S0140-6736(21)00246-4
   PubMed Web of Science ®Google Scholar
• Guerrini R, Dravet C, Genton P, et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia. 1998 May;39(5):508–512. doi: 10.1111/j.1528-1157.1998.tb01413.x
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013 Mar;12(3):244–252. doi: 10.1016/S1474-4422(12)70323-X
   PubMed Web of Science ®Google Scholar
• Symonds JD, Elliott KS, Shetty J, et al. Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants. Brain. 2021 Oct 22;144(9):2879–2891. doi: 10.1093/brain/awab162
   PubMedGoogle Scholar
• Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014 Apr;55(4):475–482. doi: 10.1111/epi.12550
   PubMed Web of Science ®Google Scholar
• Surana P, Symonds JD, Srivastava P, et al. Infantile spasms: etiology, lead time and treatment response in a resource limited setting. Epilepsy Behav Rep. 2020;14:100397. doi: 10.1016/j.ebr.2020.100397
   PubMedGoogle Scholar
• O’Callaghan FJK, Edwards SW, Alber FD, et al. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial. Lancet Child Adolesc Health. 2018 Oct;2(10):715–725. doi: 10.1016/S2352-4642(18)30244-X
   PubMedGoogle Scholar
• Chaves J, Sander JW. Seizure aggravation in idiopathic generalized epilepsies. Epilepsia. 2005;46(Suppl 9):133–139. doi: 10.1111/j.1528-1167.2005.00325.x
   PubMedGoogle Scholar
• Perucca E, Gram L, Avanzini G, et al. Antiepileptic drugs as a cause of worsening seizures. Epilepsia. 1998 Jan;39(1):5–17. doi: 10.1111/j.1528-1157.1998.tb01268.x
   PubMed Web of Science ®Google Scholar
• Ferlazzo E, Trenite DK, Haan GJ, et al. Update on pharmacological treatment of progressive myoclonus epilepsies. Curr Pharm Des. 2017;23(37):5662–5666. doi: 10.2174/1381612823666170809114654
   PubMed Web of Science ®Google Scholar
• de Lange IM, Gunning B, Sonsma ACM, et al. Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes. Epilepsia. 2018 Jun;59(6):1154–1165. doi: 10.1111/epi.14191
   PubMed Web of Science ®Google Scholar
• Sands TT, Balestri M, Bellini G, et al. Rapid and safe response to low-dose carbamazepine in neonatal epilepsy. Epilepsia. 2016 Dec;57(12):2019–2030. doi: 10.1111/epi.13596
   PubMed Web of Science ®Google Scholar
• Pisano T, Numis AL, Heavin SB, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia. 2015 May;56(5):685–691. doi: 10.1111/epi.12984
   PubMed Web of Science ®Google Scholar
• Wheless JW, Fulton SP, Mudigoudar BD. Dravet syndrome: a review of current management. Pediatr Neurol. 2020 Jun;107:28–40. doi: 10.1016/j.pediatrneurol.2020.01.005
   PubMed Web of Science ®Google Scholar
• Cross JH, Auvin S, Falip M, et al. Expert opinion on the management of lennox-gastaut syndrome: treatment algorithms and practical considerations. Front Neurol. 2017;8:505. doi: 10.3389/fneur.2017.00505
   PubMed Web of Science ®Google Scholar
• Knupp KG, Scheffer IE, Ceulemans B, et al. Efficacy and safety of fenfluramine for the treatment of seizures associated with lennox-gastaut syndrome: a randomized clinical trial. JAMA Neurol. 2022 Jun 1;79(6):554–564. doi: 10.1001/jamaneurol.2022.0829
   PubMed Web of Science ®Google Scholar
• de Lange IM, Koudijs MJ, van ‘t Slot R, et al. Assessment of parental mosaicism in SCN1A-related epilepsy by single-molecule molecular inversion probes and next-generation sequencing. J Med Genet. 2019 Feb;56(2):75–80. doi: 10.1136/jmedgenet-2018-105672
   PubMed Web of Science ®Google Scholar
• Knowles JK, Helbig I, Metcalf CS, et al. Precision medicine for genetic epilepsy on the horizon: recent advances, present challenges, and suggestions for continued progress. Epilepsia. 2022 Oct;63(10):2461–2475. doi: 10.1111/epi.17332
   PubMed Web of Science ®Google Scholar
• Ruggiero SM, Xian J, Helbig I. The current landscape of epilepsy genetics: where are we, and where are we going? Curr Opin Neurol. 2023 Apr 1;36(2):86–94.
   PubMed Web of Science ®Google Scholar
• Duncan JS, Trimmel K. Advanced neuroimaging techniques in epilepsy. Curr Opin Neurol. 2022 Apr 1;35(2):189–195.
   PubMed Web of Science ®Google Scholar
• Johannesen KM. From precision diagnosis to precision treatment in epilepsy. Nat Rev Neurol. 2023 Feb;19(2):69–70. doi: 10.1038/s41582-022-00756-0
   PubMed Web of Science ®Google Scholar
• Bertocchi I, Cambiaghi M, Hasan MT. Advances toward precision therapeutics for developmental and epileptic encephalopathies. Front Neurosci. 2023;17:1140679. doi: 10.3389/fnins.2023.1140679
   PubMed Web of Science ®Google Scholar
• Asadi-Pooya AA. Precision medicine in epilepsy management; GET application (gene, epilepsy, treatment). Clin Neuropharmacol. 2023 May 1;46(3):95–97.
   PubMed Web of Science ®Google Scholar
• Specchio N, Pietrafusa N, Perucca E, et al. New paradigms for the treatment of pediatric monogenic epilepsies: progressing toward precision medicine. Epilepsy Behav. 2022 Jun;131(Pt B):107961. doi: 10.1016/j.yebeh.2021.107961
   PubMedGoogle Scholar
• Sullivan J, Wirrell EC. Dravet syndrome as an example of precision medicine in epilepsy. Epilepsy Curr. 2023 Jan;23(1):4–7. doi: 10.1177/15357597221106281
   PubMed Web of Science ®Google Scholar
• Brunklaus A, Feng T, Brunger T, et al. Gene variant effects across sodium channelopathies predict function and guide precision therapy. Brain. 2022 Dec 19;145(12):4275–4286. doi: 10.1093/brain/awac006
   PubMed Web of Science ®Google Scholar
• Haridas B, Kossoff EH. Dietary treatments for epilepsy. Neurol Clin. 2022 Nov;40(4):785–797. doi: 10.1016/j.ncl.2022.03.009
   PubMed Web of Science ®Google Scholar
• Mastrangelo M, Cesario S. Update on the treatment of vitamin B6 dependent epilepsies. Expert Rev Neurother. 2019 Nov;19(11):1135–1147. doi: 10.1080/14737175.2019.1648212
   PubMed Web of Science ®Google Scholar
• Fitzgerald MP, Fiannacca M, Smith DM, et al. Treatment responsiveness in KCNT1-related epilepsy. Neurotherapeutics. 2019 Jul;16(3):848–857. doi: 10.1007/s13311-019-00739-y
   PubMed Web of Science ®Google Scholar
• Xu D, Chen S, Yang J, et al. Precision therapy with quinidine of KCNT1-related epileptic disorders: a systematic review. Br J Clin Pharmacol. 2022 Dec;88(12):5096–5112. doi: 10.1111/bcp.15479
   PubMed Web of Science ®Google Scholar
• Franz DN, Lawson JA, Yapici Z, et al. Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: results from the postextension phase of EXIST-3. Epilepsia. 2021 Dec;62(12):3029–3041. doi: 10.1111/epi.17099
   PubMed Web of Science ®Google Scholar
• Moloney PB, Kearney H, Benson KA, et al. Everolimus precision therapy for the GATOR1-related epilepsies: a case series. Eur J Neurol. 2023 Jul 9. doi: 10.1111/ene.15975
   PubMed Web of Science ®Google Scholar
• Billakota S, Andresen JM, Gay BC, et al. Personalized medicine: vinpocetine to reverse effects of GABRB3 mutation. Epilepsia. 2019 Dec;60(12):2459–2465. doi: 10.1111/epi.16394
   PubMed Web of Science ®Google Scholar
• Mullier B, Wolff C, Sands ZA, et al. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors. Neuropharmacology. 2017 Sep 1;123:322–331.
   PubMed Web of Science ®Google Scholar
• Singh R, Sarangi SC, Singh S, et al. A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis. Seizure. 2022 Oct;101:253–261.
   PubMed Web of Science ®Google Scholar
• Balestrini S, Chiarello D, Gogou M, et al. Real-life survey of pitfalls and successes of precision medicine in genetic epilepsies. J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1044–1052. doi: 10.1136/jnnp-2020-325932
   PubMed Web of Science ®Google Scholar
• Koch NA, Sonnenberg L, Hedrich UBS, et al. Loss or gain of function? Effects of ion channel mutations on neuronal firing depend on the neuron type. Front Neurol. 2023;14:1194811. doi: 10.3389/fneur.2023.1194811
   PubMed Web of Science ®Google Scholar
• Jirsa V, Wang H, Triebkorn P, et al. Personalised virtual brain models in epilepsy. Lancet Neurol. 2023 May;22(5):443–454. doi: 10.1016/S1474-4422(23)00008-X
   PubMed Web of Science ®Google Scholar
• Palmer EE, Howell K, Scheffer IE. Natural history studies and clinical trial readiness for genetic developmental and epileptic encephalopathies. Neurotherapeutics. 2021 Jul;18(3):1432–1444. doi: 10.1007/s13311-021-01133-3
   PubMed Web of Science ®Google Scholar
• Nabbout R, Belousova E, Benedik MP, et al. Epilepsy in tuberous sclerosis complex: findings from the TOSCA study. Epilepsia Open. 2019 Mar;4(1):73–84. doi: 10.1002/epi4.12286
   PubMedGoogle Scholar
• Gupta A, de Bruyn G, Tousseyn S, et al. Epilepsy and neurodevelopmental comorbidities in tuberous sclerosis complex: a natural history study. Pediatr Neurol. 2020 May;106:10–16.
   PubMed Web of Science ®Google Scholar
• Specchio N, Di Micco V, Trivisano M, et al. The epilepsy-autism spectrum disorder phenotype in the era of molecular genetics and precision therapy. Epilepsia. 2022 Jan;63(1):6–21. doi: 10.1111/epi.17115
   PubMed Web of Science ®Google Scholar
• Aronica E, Specchio N, Luinenburg MJ, et al. Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy. Brain. 2023 Jul 3;146(7):2694–2710. doi: 10.1093/brain/awad048
   PubMed Web of Science ®Google Scholar
• Specchio N, Curatolo P. Developmental and epileptic encephalopathies: what we do and do not know. Brain. 2021 Feb 12;144(1):32–43.
   PubMedGoogle Scholar
• Lesca G, Baumgartner T, Monin P, et al. Genetic causes of rare and common epilepsies: what should the epileptologist know? Eur J Med Genet. 2022 Sep;65(9):104570. doi: 10.1016/j.ejmg.2022.104570
   PubMed Web of Science ®Google Scholar
• Touraine R, Hauet Q, Harzallah I, et al. Tuberous sclerosis complex: genetic counselling and perinatal follow-up. Arch Pediatr. 2022 Dec;29(5S):S53–S57. doi: 10.1016/S0929-693X(22)00283-4
   Google Scholar
• Moavero R, Santarone ME, Galasso C, et al. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy. Brain Dev. 2017 Jun;39(6):464–469. doi: 10.1016/j.braindev.2017.01.006
   PubMed Web of Science ®Google Scholar
• Buraniqi E, Dabaja H, Wirrell EC. Impact of antiseizure medications on appetite and weight in children. Paediatr Drugs. 2022 Jul;24(4):335–363. doi: 10.1007/s40272-022-00505-2
   PubMed Web of Science ®Google Scholar
• Besag FMC, Vasey MJ. Neurocognitive effects of antiseizure medications in children and adolescents with epilepsy. Paediatr Drugs. 2021 May;23(3):253–286. doi: 10.1007/s40272-021-00448-0
   PubMed Web of Science ®Google Scholar
• Strzelczyk A, Schubert-Bast S. Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies. CNS Drugs. 2022 Oct;36(10):1079–1111. doi: 10.1007/s40263-022-00955-9
   PubMed Web of Science ®Google Scholar
• Baca CB, Vickrey BG, Caplan R, et al. Psychiatric and medical comorbidity and quality of life outcomes in childhood-onset epilepsy. Pediatrics. 2011 Dec;128(6):e1532–43. doi: 10.1542/peds.2011-0245
   PubMed Web of Science ®Google Scholar
• Auvin S, Wirrell E, Donald KA, et al. Systematic review of the screening, diagnosis, and management of ADHD in children with epilepsy. Consensus paper of the task force on comorbidities of the ILAE pediatric commission. Epilepsia. 2018 Oct;59(10):1867–1880. doi: 10.1111/epi.14549
   PubMed Web of Science ®Google Scholar
• Rheims S, Auvin S. Attention deficit/hyperactivity disorder and epilepsy. Curr Opin Neurol. 2021 Apr 1;34(2):219–225.
   PubMed Web of Science ®Google Scholar
• Vidaurre J, Twanow JDE. Attention deficit hyperactivity disorder and associated cognitive dysfunction in pediatric epilepsy. Semin Pediatr Neurol. 2017 Nov;24(4):282–291. doi: 10.1016/j.spen.2017.10.009
   PubMed Web of Science ®Google Scholar
• Maguire MJ, Marson AG, Nevitt SJ. Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. 2021 Apr 16;4(4). CD010682. doi: 10.1002/14651858.CD010682.pub3.
   PubMedGoogle Scholar
• Hesdorffer DC, Hauser WA, Annegers JF, et al. Major depression is a risk factor for seizures in older adults. Ann Neurol. 2000 Feb;47(2):246–249. doi: 10.1002/1531-8249(200002)47:2<246:AID-ANA17>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006 Jan;59(1):35–41. doi: 10.1002/ana.20685
   PubMed Web of Science ®Google Scholar
• Kanner AM, Schachter SC, Barry JJ, et al. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav. 2012 Jun;24(2):156–168. doi: 10.1016/j.yebeh.2012.01.007
   PubMed Web of Science ®Google Scholar
• Nilsson FM, Kessing LV, Bolwig TG. On the increased risk of developing late-onset epilepsy for patients with major affective disorder. J Affect Disord. 2003 Sep;76(1–3):39–48. doi: 10.1016/S0165-0327(02)00061-7
   PubMed Web of Science ®Google Scholar
• Kanner AM. Depression and epilepsy: a review of multiple facets of their close relation. Neurol Clin. 2009 Nov;27(4):865–880. doi: 10.1016/j.ncl.2009.08.002
   PubMed Web of Science ®Google Scholar
• Hitiris N, Mohanraj R, Norrie J, et al. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007 Jul;75(2–3):192–196. doi: 10.1016/j.eplepsyres.2007.06.003
   PubMed Web of Science ®Google Scholar
• Petrovski S, Szoeke CE, Jones NC, et al. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology. 2010 Sep 14;75(11):1015–1021. doi: 10.1212/WNL.0b013e3181f25b16
   PubMed Web of Science ®Google Scholar
• Metternich B, Wagner K, Brandt A, et al. Preoperative depressive symptoms predict postoperative seizure outcome in temporal and frontal lobe epilepsy. Epilepsy Behav. 2009 Dec;16(4):622–628. doi: 10.1016/j.yebeh.2009.09.017
   PubMed Web of Science ®Google Scholar
• Moore JL, Carvalho DZ, St Louis EK, et al. Sleep and epilepsy: a focused review of pathophysiology, clinical syndromes, co-morbidities, and therapy. Neurotherapeutics. 2021 Jan;18(1):170–180. doi: 10.1007/s13311-021-01021-w
   PubMed Web of Science ®Google Scholar
• Williams J, Sharp GB, DelosReyes E, et al. Symptom differences in children with absence seizures versus inattention. Epilepsy Behav. 2002 Jun;3(3):245–248. doi: 10.1016/S1525-5050(02)00007-0
   PubMed Web of Science ®Google Scholar
• Kwon CS, Wirrell EC, Jette N. Autism spectrum disorder and epilepsy. Neurol Clin. 2022 Nov;40(4):831–847. doi: 10.1016/j.ncl.2022.03.011
   PubMed Web of Science ®Google Scholar